Departments of Radiology and Internal Medicine, Michigan Medicine and University of Michigan, Ann Arbor, Michigan, USA.
Department of Surgery, University of Washington, Seattle, Washington, USA.
Cancer. 2024 Dec 1;130(23):3948-3960. doi: 10.1002/cncr.35385. Epub 2024 Sep 20.
Lung cancer is the leading cause of cancer death in the United States and across the world. The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) was established in 2017 as a consortium of public, private, and voluntary organizations with a mission to lower the impact of lung cancer via prevention, early detection, and optimal therapy. The ACS NLCRT supports a comprehensive scope of work that covers the lung cancer continuum, from risk reduction, tobacco prevention and control, and early detection (screening and incidental lung nodule management) to guideline-based staging, biomarker testing, treatment, and survivorship and overarching issues such as stigma and nihilism, health equity, and tactical approaches such as state coalition efforts and policy initiatives. Applying a multidimensional and multisector approach, over 220 public, private, and government agency member organizations and 250 volunteer experts, patients, and caregiver advocate representatives collaborate to address challenges across the lung cancer continuum by catalyzing action to conceive, build, and strengthen innovative solutions. The wide-ranging membership allows the ACS NLCRT to harness the collective power and expertise of the entire lung cancer community by connecting leaders, communities, and systems to improve equity and access. These national, state, and local relationships provide partnerships for the dissemination of ACS NLCRT-developed tools and resources. This article describes the ACS NLCRT and introduces the series of accompanying and future articles that together make up the ACS NLCRT strategic plan, which provides a roadmap for future research, investment, and collaboration to reduce lung cancer mortality and lung cancer-related stigma and enhance survivorship.
肺癌是美国和全球癌症死亡的主要原因。美国癌症协会国家肺癌圆桌会议（ACS NLCRT）成立于 2017 年，是一个由公共、私营和志愿组织组成的联盟，其使命是通过预防、早期发现和最佳治疗来降低肺癌的影响。ACS NLCRT 支持广泛的工作范围，涵盖了肺癌的整个连续体，从风险降低、烟草预防和控制以及早期检测（筛查和偶然肺结节管理）到基于指南的分期、生物标志物检测、治疗和生存以及总体问题，如耻辱和虚无主义、健康公平以及战术方法，如州联盟努力和政策倡议。通过采用多维和多部门的方法，超过 220 个公共、私营和政府机构成员组织和 250 名志愿专家、患者和护理人员倡导代表合作，通过催化行动来构思、建立和加强创新解决方案，解决整个肺癌连续体的挑战。广泛的成员资格使 ACS NLCRT 能够通过将领导者、社区和系统联系起来，利用整个肺癌社区的集体力量和专业知识，来提高公平性和可及性。这些国家、州和地方关系为传播 ACS NLCRT 开发的工具和资源提供了合作伙伴关系。本文介绍了 ACS NLCRT，并介绍了一系列伴随的和未来的文章，这些文章共同构成了 ACS NLCRT 的战略计划，为未来的研究、投资和合作提供了减少肺癌死亡率和肺癌相关耻辱感以及提高生存机会的路线图。
